Diabetes, Heart and Cardiovascular Diseases News Chronicle.  Diabetes, Cardiovascular and Heart Diseases
 Article 266
    Published on November 18, 2017

COMPASS Study Shows Superior Treatment With The Combination Of Aspirin And Rivaroxaban Drugs For Heart Attack, Stroke And Cardiovascular Diseases

COMPASS study (Cardiovascular Outcomes for People Using Anticoagulation Strategies study) done by the researchers from the McMaster University found that a treatment to prevent further heart complications with aspirin and rivaroxaban drugs combination is superior when compared with aspirin alone in individuals with the vascular disease. The study involved 27,395 patients with stable atherosclerotic vascular disease from 33 countries. The study was intended to find out superior treatment to prevent stroke, heart attack and death between the rivaroxaban drug and the combination of rivaroxaban and aspirin drugs.

Researchers compared rivaroxaban (2.5 mg dose twice-daily) combined with aspirin (100 mg dose once-daily) to rivaroxaban (5 mg dose twice daily) or aspirin (100 mg once-daily). The study findings show rivaroxaban and aspirin drug combination reduces cardiovascular events and the drug combination treatment is better than only rivaroxaban or only aspirin medication. Improvement in the stable coronary artery disease or peripheral artery disease (PAD) and increase the chances of a major bleeding (mainly in gastroenterological) were found with the drug combination treatment. The study also shows the drug combination treatment is superior to aspirin for the risk of limitation of blood flow to a limb or losing limbs among peripheral artery disease (PAD) patients. The risk of major cardiovascular events reduces by 19 percent with aspirin drug. But rivaroxaban and aspirin drugs combination reduces

  • Major cardiovascular event risk by 25 percent
  • Damage to limbs risk by 46 percent
  • Risk of stroke, heart attack or cardiovascular death by 28 percent

Aspirin And Rivaroxaban Drugs Combination For Heart Attack Stroke Cardiovascular Disease Treatment.

But aspirin drug alone is better compared with rivaroxaban drug alone in preventing stroke, heart attack, cardiovascular death or limb events. Lead authors of the study were Dr. John W. Eikelboom, Associate Professor, Hematology & Thromboembolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. The study findings were published on November 10, 2017, in The Lancet. Title of the article was "Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomized, double-blind, placebo-controlled trial."

Post a message on social media and mail to your friend. Article address is (copy and paste the code below) :

Articles similar to this topic

1. AT04A vaccine reduces LDL cholesterol and atherosclerosis to prevent heart disease
2. Inflammation hormones risk with glucose-gobbling immune cells hidden in plaque of coronary artery disease CAD patients
3. Aspirin may cut breast cancer risk for women with diabetes
4. A single injection of HDL or GOOD cholesterol can limit heart attack damage and improves heart function
5. Consumption of artificial sweeteners was linked to type 2 diabetes, weight gain and heart disease
6. Cafestol substance present in coffee could prevent or delay type 2 diabetes
7. Reduced heart inflammation by eating brightly colored lutein carotenoid vegetables
8. Beta-blockers may reverse genetic changes from heart failure and heart disease
9. Usage of anabolic androgenic steroids could cause heart attack and heart disease
10. Breastfeeding lowers heart disease and stroke risk for women after pregnancy


Anticoagulant : Anticoagulant medicines help in preventing blood clot formation in heart attack and stroke risk patients. Xarelto is the popular brand name for the anticoagulant.

Rivaroxaban : Rivaroxaban is an anticoagulant oral medication sold under the Xarelto brand name to prevent blood clots.


More Than 25 Percent Of Coronary Artery Disease And Heart Attack Patients Have No Risk Factors

A study done by the Australian experts found a big increase in the number of patients with coronary artery disease complications among young men and women and also across all age groups without heart disease risk factors such as high blood pressure or hypertension, high blood sugar glucose levels or diabetes, high cholesterol levels, obesity or higher body mass index (BMI) and tobacco usage.

Experts reviewed 695 heart attack patients at the Royal North Shore Hospital, St Leonards, Sydney, Australia between 2006 and 2014. Researchers found 132 individuals with heart diseases but without heart disease risk factors. The study has found an increase in heart disease events from 11 percent during 2006 to 27 percent in 2014 among young men and women without heart disease risk factors.

But the researchers could not able to identify the causes of the life-threatening coronary artery disease (plaque build up in the arteries or the development of atherosclerosis) in people without heart disease risk factors.

Artery Plaque Atherosclerosis Coronary Disease In Young Men Women Without Heart Disease Risk Factors.

This study was funded by the University of Sydney and the Heart Research Australia. Senior author of the study was Dr. Gemma Figtree, Professor in Medicine, the University of Sydney and an interventional cardiologist at the Royal North Shore Hospital, (a public teaching hospital) at St Leonards, Sydney, Australia. The study findings were published on July 13, 2017, in the European Journal of Preventive Cardiology. Title of the article was "Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors."

If you like this article, please share it with a friend! Article address is (copy and paste the code below) :

Articles similar to this topic

1. Risk of coronary artery disease (CAD) and heart attack (myocardial infarction MI) with elevated calcium levels
2. Too much salt consumption may double heart failure, stroke and coronary heart disease (CHD)
3. Self-expanding (SE) stents outperform balloon-expandable (BE) stents for treating iliac artery (atherosclerosis) disease
4. DKK3 natural protein can protect against plaque formation, atherosclerosis, stroke and heart attack
5. Weekly Physical Activity Reduces Heart Risk Associated With Obesity
6. Daily Dose Of Cinnamon Reduce Heart Attack Risk Associated With High Fat Diet
7. A German Study Shows Zinc Supply Affects Heart Health
8. Vitamin B Protect Air Pollution Induced Heart Diseases
9. Exercise And Vitamin D Helps In Reducing Strokes And Heart Attacks
10. Risks To Heart Diseases With Weight Cycling, Yo-Yo Dieting Or Yo-Yo Effect




Site maps

Site map 1   Site map 2   Site map 3   Site map 4

The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.

Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.